Medicine passport

Tapentadol Retard Xiromed 250 mg tabletten met verlengde afgifte 250 mg

The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.

Active substance
Tapentadoltartraat
Strength
250 mg
Form
tablet met verlengde afgifte
ATC code
N02AX06
Registered in
Netherlands · Medical Valley Invest AB
Prescription
Prescription only
RVG
128171

Source: Geneesmiddeleninformatiebank · 2026-09-30

Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.

Listed in other countries

Spain 9 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
PALEXIA RETARD250 mg · comprimido de liberación prolongadaPrescription onlyGrünenthal Pharma S.A.73247
PALGESIC RETARD250 mg · comprimido de liberación prolongadaPrescription onlyKern Pharma S.L.88332
REMUVA250 mg · comprimido de liberación prolongadaPrescription onlyAristo Pharma Gmbh88304
TAPENTADOL RETARD SANDOZ250 mg · comprimido de liberación prolongadaPrescription onlySandoz Farmaceutica S.A.88313
TAPENTADOL RETARD STADA250 mg · comprimido de liberación prolongadaPrescription onlyLaboratorio Stada S.L.88291
TAPENTADOL RETARD ZENTIVA250 mg · comprimido de liberación prolongadaPrescription onlyZentiva K.S.88285

3 more names not shown. Source: CIMA — Centro de Información online de Medicamentos (Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)) · 2026-09-30 · Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA.

Canada 1 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
NUCYNTA EXTENDED-RELEASE250 mg · tablet (extended-release)Prescription onlyKnight Therapeutics Inc.02415615

Source: Drug Product Database (Health Canada) · 2026-09-30 · Contains information licensed under the Open Government Licence – Canada.

Same active substance, but no match for this strength and form

Countries covered: United States, Bulgaria, European Union, Spain, France, Netherlands, Canada, Switzerland. A country missing from the list may still sell this medicine: Mediclarum reads only these registers.

Register data as of 2026-09-30. Mediclarum stores nothing about you for this page. https://www.mediclarum.com/nl/en/medicines/tapentadol-retard-xiromed-250-mg-tabletten-met-verlengde-afgifte-250-mg